Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function
Fc 工程化人源化抗 HM1.24 抗体通过增强效应功能对多发性骨髓瘤具有强效的体外和体内活性
期刊:Blood
影响因子:21
doi:10.1182/blood-2011-06-364521
Yu-Tzu Tai, Holly M Horton, Sun-Young Kong, Erik Pong, Hsing Chen, Saso Cemerski, Matthew J Bernett, Duc-Hanh T Nguyen, Sher Karki, Seung Y Chu, Greg A Lazar, Nikhil C Munshi, John R Desjarlais, Kenneth C Anderson, Umesh S Muchhal